Insertion of Rule 122DD_Registration of Ethics Committee_Section
Notification - The Drugs and Cosmetics Act, 1940
- Kind: Notification
- Under: The Drugs and Cosmetics Act, 1940
Text of this notification
Tfa*£f tfo -£o i^ro-33004/99 ^oJJUStfX REGD. NO. D. L.-33004/99
3jRcT M *i9ivi*i
(Hie (Saxette of Jlttdia
EXTRAORDINARY
*TPT II—TSPrg 3—3T-13ir5 (i)
PART II—Section 3—Sub-section (i)
UlfafrU ^ U*lfVlrt
PUBLISHED BY AUTHORITY
tf. 65] ^ l ^ f r , TpraiT, W»ft 8, 2013/TOT 19, 1934
No. 65] NEW DELHI, FRIDAY, FEBRUARY 8, 2013/MAGHA 19, 1934
HI^M 3ftT MR**K *<^IU| tMk-W
H| feft, 8 W&ft, 2013
w.^Jr^r. 72(3T).—. f̂rwf̂ r 3ft? M I ? R T̂Pnft tor, 1945 <m siW wrepf
^ <£ %r f̂̂ jqij f̂ pff ^ ^ j ^ cfr^r ?RCER% 3rmftr d -̂flcA ^difrfru i\i i>
wref ^ *r?*rra, sffafa ato j r am T̂Frcft arilrPRFf, 1940 (1940 ^ 23) g>t tiro 33 ^
T̂TST tf^cT Sfk £TKT 12 ^ t 3F>$TFJ*TR chfcrqi) f ^ f r ^T STPSq, *TR?T >̂ - JM^, 3RTT£FRur,
TFT 2, ^ 3, vJ^3^ (i) cTT̂hBT 17 ^cTTf, 2012 *f T̂RcT ?T?^R $ T̂RSZT 3ft? tf^R
*c^f"i U.HMU (w?s?i f̂ TR) gft 3ff̂ "̂ xi-fi mm\m W . ^ T . R 573(3T), T̂Rkf 17 ^wi,
2012 gRT y*|Rld f̂ ETT W STT f^Rtf ^T ^ f t a r f ^ f f *T, fuffcfc ^fR* W^RT efa 3>t
W W t, ^!T W%?3 T̂, fyfWl v̂ T l̂̂ iM?) tf\ pfcRTt, f̂ RT̂ f ?T? 3Tf£RjtRT U<wRjd eft
?lf Sft, vJR?TT cPT ^ I c W M i S ^ s f t , %Tcfr*T 1% ¥ t 3T^T <f>T W f ^ c£ *$ CJITSfr
3fR ^ 5 M TFT ^ $ ;
3TTC W ^ g$t irfcRTt uM*HtlRU| ^ t 23 ^ ? n i 2012 ^ t ^TeW 3RT 3t ^ eft ;
3fk ^ r SIR^T f̂ RFft *R vjjH îyî i ^ ^ M 3frc ^?n^f <R <T>^FJ W P R SRT
m--, 3R, ^#^r ^R^JR 3Ttafa # ? JRTTER *rm*ft srf&f^T, 1940 (1940 <m 23)
cf̂ t «IRT 12 3TR SJRT 33 3RT WH ~Z\f$FJ\ ^T JP4FT cfJ# ^J, sft^T cTcf^Mt ^ d l d * K
<M % vm$ W& cf> XT̂ HT, 3fmft 3fR T̂TEPf ^FTTft f^FT, 1945 cPT 3(k ^T?f|ER ^ T
cf> fcT^ f^rfcfRJ^ f̂ RFT Ŵ fRft %, 3T5lk :-
533 GI/2013 (1)
2 THE GAZETTE OF INDIA ; EXTRAORDINARY
1. (1) $5T f ^ m t wn *ffifar ijm affrfa 3*k JRITO ?TR̂ St (cfteRr ^ t o w ) fSfcm, 2013 £ i
2. atafir aft? 3T?n̂ pr wrcft RPPT, 1945 (ftRT ^ f ^r<£ TT̂ T̂RT ^ ^ T R m <J^T -rm
f ) c£ f ^ R 122^FT c£ T T ? W RnfdR<Jd R^PT 3|?f:^snf^T %^T T̂TTTTT, 3T2TKT :--
"f^ran i22tra,- vwwv Trfitfcf ^7 v/3y^?*vu/ - (1) ?^rre ^ f t t^ Rra*r 21 ^ ^ RS)
if ^mR^ifad 3fpff% mf^R) ^ ^ R ^ ^ i tf ^ ^ t | ^ r f ^ T R ) ^ W ^ I R ^
1 ^ 3^H)<H <& f̂ TT |J«i[3d)cJH 3?R 3PRRW ̂ 3Rift ;
^ 3Tmfr 3TTT 5TCTTER ^FFBft _ ( t o j t e ) RRm, 2013 $ mi* eft cTRRf W
% F T H <Pt̂ ^ N R ^ f r f^Rf} <TFct # ^ i R c b qRSTW W r f R <J?T ^Hf3cf|cM 3
3f^ft^T <J>t ^Tf?T cfR feTT t , 3 T ^ ^ affc ITCmH W n f t £ ^ W WfltW) fom, 2013
^ 2RT efft <TRRJ %Tcfr?T f^T clot 3Jcrf£r cf> iftcR ^ R J 1 ^ < H " I 5TTKT 3R*t I
(2) ^ m R ^ t c T $ tfSR^cjRUf <# f ^ 3 ^ 3TT^T 3 T ^ J ^ *T ̂ n R R i ^ 8 $ RRfgt^
f%t%eT 3T̂ 5TT3Tf 3> 3FRROT 3 3^$lfkl 3JTfS|^t ept f^nn \3fTCpTT I
(3) ar jmf^ J n t o r f t *TF ?TT^PT ?t UTFT <F> *TC3T?T 1% 3T̂ eTT3Tt eft 3^MlcH 3R f^TT W
t ?ft CTF ^?T^ 3?f£m>f̂ T ^ f t ?raf c£ 3T0h ^ jpj W E I R ^ f e r ^ ^ R K ^ C H U I
3PTstf^ c f R ^ r j i |
(4) W ? R ^Tfafrr 3T^Jxft *T *f ^ i f ^ R ^ W *f f ^ f t ^klRcfr T R ^ ĉ 3T^r^T ^T
^Rc f ton afk ^ W T 3T^RT^T ufRT T f̂epjff ^ t tf^Rid atcRToff *R <Rkrqf ^ r ^ r 4 d U n
^FTT ^ t # 3tR ^TR^ ^ ^ jRlch TRt̂ TW ^ 'fcR 3 T ^ ^|RcJ> oqcj^K TTRt-f^T 3tk
^ T T R a r f ^ R , ^5TT rT9TT ^ a r ^ ^ 3TE& Bt% ĉ 3T£fN ^ ^ 3RJ eTT̂ RR^Hch
3T̂ §TT3Tf cfr 3T^RTR cfRift |
(5) ^|Rcf> TR>§M fer^ff f̂ ^ j R c h TRteWf ^ ^ R R f M t WR tfcR^r T̂CTT ^ ^?n ^
^KNiy ^f*rfcr ^5W& f ^ fe f^T cFRift 31R 3 T ^ ^ t T c^ wRf^ l^ 7 c^ 3T#^f R l R f ^ y f ^ q j
(6) M W ^Hftfcf, 4 > ^ i j 3rmf^r TTR^ R^JdU| ^pRR ]gRT 3^TI?^KT f^tePF^f T̂f q^TTfM
cpt ^ i R * q̂ sT°T ^r ^TCT?T f^t f t a r f ^ g , ^ra, ^IT fcMt ^ r r W m\ f^R)ar^ ^ R # CFTT
3 M ^TR^R f̂ ^?T. cFR̂T T$\ 3rpTcT cfRift 3IR ^ | R c h tR^TTf cf?t vH^lRld ^ 5 ^ ĉ W T
*f, zrsnR^fcT, ^T f ^ R t ^ t m 3fH|cblR^' gRI ^ 5 ^ TJTT f ^ f t 7 H cm ^M^cH ̂ R ^rft |
(7) ^ R ^ R O T , uIW rTcfo % ^ T Rdf^d ^ f^R^T ^ f^f^IT WT? W§t W& ^ ^RRJ ^
# ^ ^ cf?r 3Td^ ^ fdTj fcrfSrcr^i ^PTT:
^ ^ 3T55Tf% 3Tf^7Rt <f>\ ^T: ^fuR^ROI ^ fcPJ STI^T # ^ T̂RT ̂ 3T^TR
^ ^ 5fM |3TT t eft ^R^rcfRtJj ^ ^g^ ^FRI ^ T yR ficp ^RT jnf^Jc^R) sfRT 3TT&T
T̂TRd ^T# fcf̂ JT WcTT t :
(8) ^ STpff^T w f ^TRt cPT ^ TRT ÎPT ^ f FTcIT #, ^F 3tT^T W\ RR^CT ^R ^ 3tk
3TT^f? cfTT ^ f̂ R?cr ^fR^ ĉ fcPJ ^R<jff ^ t ^TcT ^RTT CTSH ̂ f f t ?T?ff cpt fyRg>t ^
^ R ^ R O T ^ tf4 "̂ RTEIR clr̂ TT ^ l ^ ^ c h #fTT, ^ ^Rl^|ch^"J| ]RtT ̂ R ^ ^ ^ 1 I
"W ," l*f^f*1 I f " ! w ' ' ^ > f * W "HWHnaiMt.1.
file:///3fTCpTT
[«im'ii—-awe 3(i)j W ^ F T wm : arorarw 3
(9) ^ ^ M K ^ r f ^ ^RU^cMUl ?tft f^§ TTcff <m 3I^qTcFT W& *t' 3 R T T 4 ^ f t £
3Fj5Tf% 5TT%cf>Rl ^Rtr[ ^TT3Tt ^ 3T^R ^ cf> TT̂ETRT % cFsft T̂ ^TT 3TT$?I <TTRcT efR
f^TT WTTT, IclRdd 3 3TT&T 5RT gjRDJf ^ e H 3 ^ 3R^ 3> ^^TcT, ^ f t 3T^T c£ foHf f^RT
(10) M W ^TftfcT I^RT^T ^ S R ^ ^ T 3T5Slf^finfim>I^ g M faeffor TIT f%^T cfR f^TT
^ t ^ 3TT î cf̂ irt?r ^ t jnt% ^ 90 f^r ^ tft<R cj^ta ?RS>R <£r artfc* =TR ?T^TT
^ H &$m ^ W R ^ ^ cf>T 3TcRR ^T 3> q?*n<T ^ 3TT&T <tft g f e *TT ^c^T *TT
^idRd cjR^cMt I
fafbctfiii, ih-$!?ilftfr WZW MlRbd %ft vi)} ®Rft ^ / ^ i?#^Y *? 3id4fcld WTcf
& niffcilm 3ifc QjHte't, 3F$wr> (wfamf) <rft \wy<Mdi, qfcr&ff affc WZI?H ftwvf
& "ffitr imft" um <i>& 3ih nh^di wftm &t mkmr & ^1^4,^1 <£ fa?
wmm g ^ m^t ^mi <& g ^ a/fa g^fcr « /H*/# <$ fen? xtriw4} wrft i"
3. Wtt faPT tft 3 T ^ f t IT Tf ^ r a R ^ f t f e ^ *RftcT TTR%^ 8 A
(3>) ^T 1 ^ W H TR 'RnfeiRdd fcr TOT WW, arafa : -
" 1 . W l < *Tfitfct cfr y f a ^ c H U I <̂ feTXT 3 ^ ^ 3TR *TPfe?fa
1. t^RTR :
^TWR *rPrt% 5Tr̂ cl7 ÎcJlRch ^Rt«TW F^TR ^T ^Tf^cftcfH ^ » t l 3TR fcp^T g>t f̂PTTf̂ T
wllRaH, WoUlRld cTPff cfJT ^ j c b H gRjft clWT t^RTT, ' / l H - t a l 3 tk T R ^Rl? t jd ^ R ^
ĉ f^rrr cjwi^wflcf>^l gft NJ4^<kldl TO^ft I ^tPlcb T^tarur cfi ^RR ^ lPl4> q^teM f^rsff
cF> WS f^fRft ift T T # ? yfd<^el ^^TT ^NT TR, <I<JNK ^TfcT f^efWT gi^f t afR ^TJ^ i t T
3> 4RR|t<i 12 ^ RPlf^^ i jrf^TT ^ 3TJfTR 3R^t ^RI ^ r f t I
2. <H<NH 'HPlf^ 3)t « '«H I :
(cT5) 0«SWI< WftfrT ^ ^ r T̂ cpT{ T̂RT ^ K ^ I # T 31R ^ T ^RWT *f TJ3J ^^Fq", 3TKreT
#TTT, (yff t% ?̂T?8n ^ ^T^f ^T | ) ; ^ W ^ r a ^ WT ^ ?T^ ^RW, Rlf^oHl, tgJTfa»
3fR ^R-f%Ttc|K#IT,ik - ^ 5 l l P i * ^ ^ T f^c f r f # r t fyRT^ 3td^fe O H H ^RcTT "ft t I
4 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)]
(U) ^ ? W cPt'^T ZfTffl ^ 3T#T. HRd 3 ^ | R c b ^ a f J I c£ fcpj 3ft& -klRcb, cZTcTgR,
(i) ^ Rlfortfk %Tf^ ;
(H) ^ iPlcb ;
(iii) M?r̂ M w ;
( i v ) fllHlfacfr ^ i P l c b ?TT ^ Wm% ^ R * c h 3fpTcWT cPT 3Tfaf%ft ^T ^ T ^IT^ft T̂T
(v) fl^cJM ^ >NHM oqfgfc |
3 T ^ 3 ik 3 T ^ Wf t tT ^ 3 ^ i fcT ^ T T ? ^ # 3JT7 ^TuT <£ ^T^^T c£ ^W A ST^T
cF5cNt sfhT G!lR|<x|i eft vl H<t> l$l ^IcTT f t I
^ w f ^?^r ?mT t ^T^W, f^rf^ffcfFf ?r ^ ^ 5 n j ^ ^<JNK ^rftft eft # ^ $
3TW ^FT cTFRT 3 ?p£, fyĴ T 3TOJ$T eft ferf^T 3 c#cf c f ^ f ? t mft ^H ^ !%cT %
fc>T̂ ^ % TRT ^T cf5T 3rfSfcm?^f #TT I
3. ^HciNK ^ r f c l c|> v f ^ ^ c h ^ u i ĉ foTtJ OTefcIeJ) gfRT ^t yTT̂ t ÎTcft uTFranfM eft
3T*r«n :
(^) HTfagiR f^RT^ SI^T ^ciNK ^PrfcT r̂f̂ cT ^ f t , ^KWdl ^ t 3 ^ a ^ , ft3?T ^ pRtR,
f ^ t % eft ?icf afk ^ r q ^ eft ^anv i
( l ) ^?T^r ĉ eMMN^, ^ % srfcR^nf^T ^rFT ^T ?2I^ ^ leT^ irf^TT !
( ^ 3[OT5T cPT T̂FT, T^T, 3T^dT ,̂ ^J|<HlcH* ^TTfir, t f c ^ f a ^3IT, ^cRT ^T?3T, -̂̂ c=T,
^ T ^^ fT, i-*m 3 i k ^T^ ^T WT I vrtHchl-51 ^ 7 K ^ t eft R ^ s l d l (m^rf^", %Tf^rT
[w\ n—-ms 3(i)] ma ^\ m^m •. smww
jjffigi; j f t Ĵ TT #> _ ^
( i ) *ftfcT gRT ^Rc f l f oc l 3cJlftef> 3T^mFT ^T 3 W ( ^ f ^ > , g f q ^ t ^ T W f ^ ,
(H) Wfrfi ^Tftcf> q%UF WETR cfr 3 * f a ^ f ^ u f f?SRT* 3 m % ^ ^TcT
(iii) ?im gSt ta^f ^ ^terr ^ « t a ^Hch^ 3fr? foftjp xr̂ arur ^ ^ ^ r ^r
«lRla4l eft te?f <& * | 4 ^ ' 35T t K d l M f r ^ q ;
® ^f aSW torn ?rft£r <$ ̂ s f f <£ f̂ n? *TH<P 5 ^ ^ srf^rarf <£ *ra a f t m eft
(3) *THcf> HUM* 5rf̂ TT3Tf cfc ?TTO %T <& S c ^ R gjf TPfre? c F R ^ M ^ ^ f^Tj ^ftfrf I
(3) ^ ^ftfcT % 3TO* ^ ^ 3 T <T%T 3T ft%W cf^RT & a l f t $ I
^ t wMt f AnfaRad c£ fen? srftete ^ ^ \ , 3rarf?r -
(*g) ?rjft ^ î̂ jff cp mcfejTĵ i ufjcR ;
(^ yrf^eft^r i> fcnr HCĤ IK, ^r^r ^rgur wr f̂ erR, HPTefi Wr^ JRW, 3P%W
^ T ^ R 3TTf̂ " cjit 3Tfcrat JRg?T ^ ^ f t #>ft ;
£23 €*TflZ-z
THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)]
(tf ^nft M W r̂ftfcT ^t fef^f eft ct7i4 t̂fl ;
(vf) 3TSTST g M ? M T d ^ l ^ W3TC ^rf̂ rfrT ^ t ^ f $ w f f c T ;
(oT) 3 j W i cf> TTRF3T c£ ^T5T fcfj^ft 3TKT3H cf> WTV ^ W\fi<\ $ fcTXJ ^TT$ ^pft
(^) 3TSRPT q5t 3TfcR ftf\£ f u R ^ 3TcT^T W ^ t^5cH, c b " W f ^ g j 3lW^T
^ c [ l f ^ ^ T ? R , H l ^ H 3 l k 3HT c ^ fffizpft rfl 3^aTT3ft ^T 3T^ToFT <fi\ ^ O ^ T cR%
^ ^ ^ T 3fafa J T H ^ f ^ t ^ l ^FfcH SNT S T ^ T ^ 3 l t a f M 3RT M m <fc feTTT
^ff^TT I
(s) "2. ^ M N f̂tfcF £ a^fcrr £ feT̂ ̂ r f^rpr" sra>f afcr rt <£ ̂ R <R, "2.
^raR ^rfttrr 5Ri -^cjiPi* i r t a HCIMH g> a ^ k n <£ fci^ wr f̂ EjR" 3 ^ afhr ?w
[ m U 133^-11014/8/2011-^1^*^]
3T?^I %. 1cTn3T, tf*pKJ Tlf^f
• q ^ faWtlT : T£rT t W T W T * , 3?fa^RT tf. T£P 2 8 - 1 0 / 4 5 - ^ (1 ) efffasf 21 f^SWT, 1945
SRT WfclcT ftn^ «f 3^k 3Tf^T ̂ mt^R 3lf* l^RT U m^T.fT. 63(3T) TTTCte 1 TR^tt, 2013
' I «•*"»!• '»»» ' f f X ' v i i W ' '""TBH"'' T i »pi ' -""imiit l . MUH^wuiiauaBii i.ii.ax. •
[qFIiI_7§TT5 3(i)] *?TOT ^ T < N M ^ : an*fl*IR«l 7
MINISTRY OF HEALTH AND FAMILY WELFARE
(Department of Health)
NOTIFICATION
New Delhi, the 8th February, 2013
G.S.R. 72(E).— Whereas a draft of certain rules further to amend the
Drugs and Cosmetics Rules, 1945, was published, as required by section 12
read with section 33 of the Drugs and Cosmetics Act, 1940 (23 of 1940), vide
notification of the Government of India, Ministry of Health and Family Welfare
(Department of Health), number G.S.R.573(E), dated the 17thJuly, 2012, in the
Gazette of India, Extraordinary, Part II, Section 3, Sub-section (i), dated the
17mJuly, 2012, inviting objections and suggestions from all persons likely to be
affected thereby before the expiry of a period of forty five days from the date on
which the copies of the Official Gazette of the said notification is published were
made available to the public;
And whereas copies of the Gazette were made available to the public on
the 23rd July. 2012;
And whereas, objections and suggestions received from the public on the
said rules have been considered by the Central Government;
Now therefore, in exercise of the powers conferred by sections 12 and 33
of the Dmgs and Cosmetics Act, 1940 (23 of 1940), the Central Governmer*
alter consultation with the Drugs Technical A J ^ ^ ^ e ^ m a k ^
following rules further to amend the Drugs and Cosmetics Rules, 1945, namely.
1. (1) These rules may be called the Drugs and Cosmetics (Third
Amendment) Rules, 2013.
(2) They shall come into force on the date of their publication in the
Official Gazette.
THE GAZETTE OF INDIA ; EXTRAORD[NARY
[PART I I^SEC
2.
ScSle Y ' ^ PSr P r 0 C e d U r e S S p e d f i e d U"d e r APPENDIX x"of
Z S e a d e o X ^ ? a " y d ° C U m e n ' r e l a , e d t 0 d i " i c a l trial and
PPMSSJ: S str~—•sha"be - *
i ; , Pr0^idfL
cl t h a t i f t h e aPP'ication for re-registration is received hv th«
* ' l * | *MIIM . liiaildlllHBIIidiMHi
Provided further that the Licensing Authority shall be informed in
writing in case of any change in the membership or the constitution of the
Ethics Committee takes place.
( 8 ) J f ^ . ' cens ing Authority is not satisfied, he shall reject the application
and shall inform the applicant of the reasons for such rejection and the
conditions which must be satisfied before the registration can be granted.
(9) If the Ethics Committee fails to comply with any of the conditions of
registration, the Licensing Authority may, after giving an opportunity to
show cause why such an order should not be passed, by an order in
writing stating the reasons therefor, suspend or cancel the registration of
the Ethics Committee for such period as considered necessary.
(10) The Ethics Committee whose registration has been suspended or
cancelled by the Licensing Authority, may, within ninety days of the receipt
of the copy of the order, prefer an appeal to the Central Government and
the Central Government may after giving an opportunity of being heard
confirm, reverse or modify such order.
Explanation.- For the purpose of this rule an Ethics Committee is a
committee comprising of medical, scientific, non-medical and non-
scientific members, whose responsibility is to ensure the protection of the
rights, safety and well-being of human subjects involved in a clinical trial
and it shall be responsible for reviewing and approving the protocol the
suitability of the investigators, facilities, methods and adequacy of
information to be used for obtaining and documenting informed consent of
the study subjects and adequacy of confidentiality safeguards.';
3. In the said rules, in Schedule Y, in Appendix Vill relating to Ethics
Committee,-
(A) for paragraph 1, the following paragraph shall be substituted, namely:-
Requirements and guidelines for registration of Ethics "I.
Committee
1. Scope:
Ethics Committee shall review every clinical trial proposal and
evaluate the possible risks to the subjects, expected benefits and
adequacy of documentation for ensuring privacy, confidentiality and
justice. In the case of any serious adverse event occurring to the
clinical trial subjects during the clinical trial, the Ethics Committee
5-33 ^x/iZ-2
10 THE GAZETTE OF INDIA : EXTRAORDINARY [PART II—SEC. 3(i)]
shall analyse and forward its opinion as per procedures specified in
APPENDIX XII of Schedule Y.
2. Composition of Ethics Committee:
(a) Ethics Committee shall consist of not less than seven members
and one among its members, who is from outside the institute,
shall be appointed as Chairman; one member as a Member
Secretary and rest of the members shall be from Medical,
Scientific, Non-medical and Non-scientific fields including lay
public.
(b) The committee shall include at least one member whose
primary area of interest or specialization is Non-scientific and at
least one member who is independent of the institution.
Besides, there should be appropriate gender representation on
the Ethids Committee.
(c) The Ethics Committee can have as its members, individuals
from other Institutions or Communities, if required.
(d) Members should be conversant with the provisions of clinical
trials under this Schedule, Good Clinical Practice Guidelines for
clinical trials in India and other regulatory requirements to
safeguard the rights, safety and well-being of the trial subjects.
(e) For review of each protocol the quorum of Ethics Committee
shall be at least five members with the following
representations:
(i) basic medical scientist (preferably one pharmacologist);
(ii) clinician;
(iii) legal expert;
(iv)social scientist or representative of non-governmental
voluntary agency or philosopher or ethicist or theologian or a
similar person;
(v) lay person from community.
<f) The members representing medical scientists and clinicians
should have Post graduate qualification and adequate
experience in their respective fields and aware of their role and
responsibilities as committee members.
(g) As far as possible, based on the requirement of research area
such as HIV, Genetic disorder, etc., specific patient group may
also be represented in the Ethics Committee.
(h) There should be no conflict of interest. The members shall
voluntarily withdraw from the Ethics Committee meeting while
making a decision on an application which evokes a conflict of
interest which may be indicated in writing to the Chairman prior
[qFTII—W^3(i)] •RRCT ̂ i mm : zmWH 11
to the review and be recorded so in the minutes. Ail members
shall sign a declaration on conflict of interest.
(i) Subject experts or other experts may be invited to the meetings
for their advice. But no such expert shall have voting rights.
3. Information required to be submitted by the applicant for
registration of Ethics Committee:
(a) Name of the Ethics Committee
(b) Authority under which the Ethics Committee has been
constituted, membership requirements, the term of
reference, conditions of appointment and the quorum
required.
(c) The procedure for resignation, replacement or removal of
members.
(d) Address of the office of the Ethics Committee.
(e) Name, address, qualification, organisational title, telephone
number, fax number, e-mait, mailing address and brief
profile of the Chairman.
(f) Names, qualifications, organisational title, telephone
number, fax number, e-mail and mailing address of the
members of the Ethics Committee. The information shall
also include member's specialty (primary, scientific or non-
scientific), member's affiliation with institutions and patient
group representation, if any.
(g) Details of the supporting staff.
(h) In the case of Ethics Committees existing before the
publication of the Drugs and Cosmetics (Third Amendment)
Rules, 2013,-
(i) type of clinical research reviewed by the committee (e.g.
pharmaceuticals, devices, epidemiological,
retrospective, herbals, etc.).
(ii) documents reviewed for every clinical trial protocol
including Informed Consent documents.
(iii) information in respect of number of meetings of the
committee and documentation of the minutes of
meetings of these committees concerning clinical trials.
(iv) information regarding review of serious adverse events
reported during the conduct of the trial.
(i) The standard operating procedures to be followed by the
committee in general.
(j) standard operating procedures to be followed by the
committee for vulnerable population.
(k) Policy regarding training for new and existing committee
members along with standard operating procedures.
£33 GTfe-t{
12
THE GAZETTE OF INDIA : EXTRAORDINARY [PART n__S E C 3 ( j ) ]
0) Policy to monitor or prevent the conflict of interest alonq
with standard operating procedures.
(m) If the committee has been audited or inspected before give
details. ' a
4. Maintenance of Record:
All documentation and communication of an Ethics Committee are to
oe dated, filed and preserved according to the standard operatinq
procedures. Strict confidentiality shall be maintained during access
and retrieval procedures. Records should be maintained for the
following, namely:-
(a)The constitution and composition of the Ethics
Committee;
(b) The curriculum vitae of all the committee members-
(c) Standard operating procedures followed by the
committee;
(d) National and international guidelines;
(e) Copies of the protocol, data collection formats, Case
Report Forms, Investigator's brochures, etc., submitted
for review;
(f) All correspondence with committee members and
Investigators regarding application, decision and follow
up;
(g) Agenda of all Ethics Committee meetings;
(h) Minutes of all Ethics Committee meetings with signature
of the Chairman;
(i) Copies of decisions communicated to the applicants
(j) Record of all notification issued for premature termination
of a study with a summary of the reasons;
(k) Final report of the study including microfilms, compact
disks or Video-recordings.
All records shall be safely maintained after the completion or
termination of the study for not less than five years from the date of
completion or termination of the trial (Both in hard and soft copies).
5 The Ethics Committee shall be open to inspection by the officers
authorised by the Central Drugs Standard Control Organisation who
may include an officer of the State Drug Control Authority concerned
to verify compliance to the requirements of Schedule Y, Good Clinical
Practices guidelines and other applicable regulationfor safeguarding
the rights, safety and well-being of the trial subjects "•
[W\ II—WZ 3(i)] ÎTCW ^RTIFSR^ : aramTFI 13
(B) for the figure and words "2. Format for Approval of Ethics Committee",
the figure and words "III. Format for According Approval to clinical trial
protocol by the Ethics Committee." shall be substituted.
[F. No. X-11014/8/2011-DFQC]
ARUN K. PANDA, Jt.Secy.
Foot Note j— The principal rules were pubHshed in the Official Gazette vide
notification No. F.28-10/45-H (1), dated 21st December 1945 and last amended
vide notification number G.S.R. 63(E), dated the 1st February, 2013.
Printed by the Manager, Government of India Press, Ring Road, Mayapuri, New Delhi-110064
and Published by the Controller of Publications, Delhi-110054.